Skip to main content

Taiga Biotechnologies important milestone

Taiga Biotechnologies important milestone

Reaching a

Optimapharm is pleased to announce we have reached an important milestone on Taiga Biotechnologies Inc. TBX-2400-01 study initiating first site in Croatia for patients undergoing hematopoietic stem cell transplant (HSCT).

#teamOptimapharm is excited for continuation of collaboration with Taiga Biotechnologies and proud to support them in the fight against blood cancers.

Read the full article at:

For more information about clinical trial please visit:

“I wanted to say thank you for your superb support and collaboration this year. I am looking forward to work with you in 2019 as it is a pleasure to work with you and your team.”

Senior Manager Partner

Let’s talk about your pharma study needs